Defining neurodegeneration on Guam by targeted genomic sequencing
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Objective: Amyotrophic lateral sclerosis/parkinsonism–dementia complex has been described in Guam, Western Papua, and the Kii Peninsula of Japan. The etiology and pathogenesis of this complex neurodegenerative disease remains enigmatic. Methods: In this study, we have used targeted genomic sequencing to evaluate the contribution of genetic variability in the pathogenesis of amyotrophic lateral sclerosis, parkinsonism, and dementia in Guamanian Chamorros. Results: Genes previously linked to or associated with amyotrophic lateral sclerosis, parkinsonism, dementia, and related neurodegenerative syndromes were sequenced in Chamorro subjects living in the Mariana Islands. Homozygous PINK1 p.L347P, heterozygous DCTN1 p.T54I, FUS p.P431L, and HTT (42 CAG repeats) were identified as pathogenic mutations. Interpretation: The findings explain the clinical, pathologic, and genetic heterogeneity observed in some multi‐incident families and contribute to the excess incidence of neurodegeneration previously reported on Guam. Ann Neurol 2015;77:458–468
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433
MutationTaster evaluates disease-causing potential of sequence alterations
Schwarz, J. M., Rödelsperger, C., Schuelke, M., & Seelow, D. (2010) · Nature Methods · doi:10.1038/nmeth0810-575 · Cited by 2,975 · cited 2×
“The latter includes a normalized conservation score from the UCSC Genome Browser(23) and PHAST PhyloP(24) as well as prediction scores from SIFT,(25) PolyPhen2,(26) and MutationTaster.(27) Control data were also extracted from the 1000 Genomes Project (ftp://ftp-trace.”
MethodMutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia
Skibinski, G., Parkinson, N. J., Brown, J. M., Chakrabarti, L., Lloyd, S. L., Hummerich, H., Nielsen, J. E., Hodges, J. R., Spillantini, M. G., Thusgaard, T., et al. (2005) · Nature Genetics · doi:10.1038/ng1609 · Cited by 822 · cited 1×
“CHMP2B mutations have been linked to dominantly inherited frontotemporal dementia (FTD) that typically manifests in midlife (48–57 years), often with parkinsonism as a later feature.(39,40) A novel CHMP2B mutation, affecting a conserved residue and predicted to be damaging to protein function, was identified in a pati…”
BackgroundThe UCSC Genome Browser database: 2014 update
Karolchik, D., Barber, G. P., Casper, J., Clawson, H., Cline, M. S., Diekhans, M., Dreszer, T. R., Fujita, P. A., Guruvadoo, L., Haeussler, M., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1168 · Cited by 670
Yu, C.-E., Bird, T. D., Bekris, L. M., Montine, T. J., Leverenz, J. B., Steinbart, E., Galloway, N. M., Feldman, H., Woltjer, R., Miller, C. A., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2009.328 · Cited by 190 · cited 1×
“The majority of GRN mutations described in FTD without tau pathology are either nonsense or splicing substitutions resulting in the insertion of a premature stop codon and ultimately leading to reduced protein levels due to nonsense-mediated mRNA decay.(41) The novel GRN mutation is a missense substitution predicted t…”
Background
Cited by
Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential
Henrich, M. T., Oertel, W. H., Surmeier, D. J., & Geibl, F. F. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00676-7 · Cited by 406
Truban, D., Hou, X., Caulfield, T. R., Fiesel, F. C., & Springer, W. (2016) · Journal of Parkinson’s Disease · doi:10.3233/jpd-160989 · Cited by 237
“Keywords: Parkinson’s disease, PINK1, Parkin, ubiquitin, mitochondria, mitophagy”
Potential PINK1 Founder Effect in Polynesia Causing Early‐Onset Parkinson's Disease
Patel, S. G., Buchanan, C. M., Mulroy, E., Simpson, M., Reid, H. A., Drake, K. M., Merriman, M. E., Phipps‐Green, A., Cadzow, M., Merriman, T. R., et al. (2021) · Movement Disorders · doi:10.1002/mds.28665 · Cited by 22
PTEN-Induced Putative Kinase 1 Dysfunction Accelerates Synucleinopathy
Nguyen, T. T., Kim, Y. J., Lai, T. T., Nguyen, P. T., Koh, Y. H., Nguyen, L. T. N., Ma, H.-I., & Kim, Y. E. (2022) · Journal of Parkinson's Disease · doi:10.3233/jpd-213065 · Cited by 8
Human iPSC Models in Drug Discovery: Opportunities and Challenges
Silva, M. C., Cross, A., Brandon, N. J., & Haggarty, S. J. (2017) · Comprehensive Medicinal Chemistry III · doi:10.1016/b978-0-12-409547-2.12284-x · Cited by 6
Metadata
- Authors
- Steele, J. C., Guella, I., Szu‐Tu, C., Lin, M. K., Thompson, C., Evans, D. M., Sherman, H. E., Vilariño‐Güell, C., Gwinn, K., Morris, H., Dickson, D. W., & Farrer, M. J.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2015-02-03
- Volume
- 77
- Issue
- 3
- Pages
- 458-468
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2137077630
- Cited by
- 67
- References
- 5
- FWCI
- 5.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Defining neurodegeneration on Guam by targeted genomic sequencing. https://app.cochat.ai/papers/10.1002/ana.24346
- The paper
- Steele, J. C., Guella, I., Szu‐Tu, C., Lin, M. K., Thompson, C., Evans, D. M., Sherman, H. E., Vilariño‐Güell, C., Gwinn, K., Morris, H., Dickson, D. W., & Farrer, M. J. (2015). Defining neurodegeneration on Guam by targeted genomic sequencing. Annals of Neurology. https://doi.org/10.1002/ana.24346
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.